TY - JOUR
T1 - Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease
AU - Helgadottir, Anna
AU - Gretarsdottir, Solveig
AU - Thorleifsson, Gudmar
AU - Hjartarson, Eirikur
AU - Sigurdsson, Asgeir
AU - Magnusdottir, Audur
AU - Jonasdottir, Aslaug
AU - Kristjansson, Helgi
AU - Sulem, Patrick
AU - Oddsson, Asmundur
AU - Sveinbjornsson, Gardar
AU - Steinthorsdottir, Valgerdur
AU - Rafnar, Thorunn
AU - Masson, Gisli
AU - Jonsdottir, Ingileif
AU - Olafsson, Isleifur
AU - Eyjolfsson, Gudmundur I.
AU - Sigurdardottir, Olof
AU - Daneshpour, Maryam S.
AU - Khalili, Davood
AU - Azizi, Fereidoun
AU - Swinkels, Dorine W.
AU - Kiemeney, Lambertus
AU - Quyyumi, Arshed A.
AU - Levey, Allan I.
AU - Patel, Riyaz S.
AU - Hayek, Salim S.
AU - Gudmundsdottir, Ingibjorg J.
AU - Thorgeirsson, Gudmundur
AU - Thorsteinsdottir, Unnur
AU - Gudbjartsson, Daniel F.
AU - Holm, Hilma
AU - Stefansson, Kari
N1 - Publisher Copyright:
© 2016 Nature America, Inc.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Sequence variants affecting blood lipids and coronary artery disease (CAD) may enhance understanding of the atherogenicity of lipid fractions. Using a large resource of whole-genome sequence data, we examined rare and low-frequency variants for association with non-HDL cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides in up to 119,146 Icelanders. We discovered 13 variants with large effects (within ANGPTL3, APOB, ABCA1, NR1H3, APOA1, LIPC, CETP, LDLR, and APOC1) and replicated 14 variants. Five variants within PCSK9, APOA1, ANGPTL4, and LDLR associate with CAD (33,090 cases and 236,254 controls). We used genetic risk scores for the lipid fractions to examine their causal relationship with CAD. The non-HDL cholesterol genetic risk score associates most strongly with CAD (P = 2.7 × 10 -28), and no other genetic risk score associates with CAD after accounting for non-HDL cholesterol. The genetic risk score for non-HDL cholesterol confers CAD risk beyond that of LDL cholesterol (P = 5.5 × 10 -8), suggesting that targeting atherogenic remnant cholesterol may reduce cardiovascular risk.
AB - Sequence variants affecting blood lipids and coronary artery disease (CAD) may enhance understanding of the atherogenicity of lipid fractions. Using a large resource of whole-genome sequence data, we examined rare and low-frequency variants for association with non-HDL cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides in up to 119,146 Icelanders. We discovered 13 variants with large effects (within ANGPTL3, APOB, ABCA1, NR1H3, APOA1, LIPC, CETP, LDLR, and APOC1) and replicated 14 variants. Five variants within PCSK9, APOA1, ANGPTL4, and LDLR associate with CAD (33,090 cases and 236,254 controls). We used genetic risk scores for the lipid fractions to examine their causal relationship with CAD. The non-HDL cholesterol genetic risk score associates most strongly with CAD (P = 2.7 × 10 -28), and no other genetic risk score associates with CAD after accounting for non-HDL cholesterol. The genetic risk score for non-HDL cholesterol confers CAD risk beyond that of LDL cholesterol (P = 5.5 × 10 -8), suggesting that targeting atherogenic remnant cholesterol may reduce cardiovascular risk.
UR - http://www.scopus.com/inward/record.url?scp=84965036429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84965036429&partnerID=8YFLogxK
U2 - 10.1038/ng.3561
DO - 10.1038/ng.3561
M3 - Article
C2 - 27135400
AN - SCOPUS:84965036429
SN - 1061-4036
VL - 48
SP - 634
EP - 639
JO - Nature Genetics
JF - Nature Genetics
IS - 6
ER -